Back
Cellectar Biosciences Stock Price Chart
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Sell
44
CLRB
Cellectar Biosciences
Last Price:
2.10
Seasonality Move:
-15.64%
7 Day Trial
ALL ACCESS PASS
$
7
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing selling pressure, which indicates risk of future bearish movement.
Cellectar Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.11 | Buy |
| 20-day SMA: | 2.13 | Sell |
| 50-day SMA: | 2.19 | Sell |
| 200-day SMA: | 2.99 | Sell |
| 8-day EMA: | 2.11 | Buy |
| 20-day EMA: | 2.12 | Sell |
| 50-day EMA: | 2.24 | Sell |
| 200-day EMA: | 2.67 | Sell |
Cellectar Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 47.36 | Sell |
| Chaikin Money Flow: | -173871 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.07 - 2.17) | Sell |
| Bollinger Bands (100): | (2.1 - 3.08) | Sell |
Cellectar Biosciences Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cellectar Biosciences Stock
Is Cellectar Biosciences Stock a Buy?
- Cellectar Biosciences share price is 2.11 while CLRB 8-day simple moving average is 2.11, which is a Buy signal.
- The stock price of CLRB is 2.11 while Cellectar Biosciences 20-day SMA is 2.13, which makes it a Sell.
- Cellectar Biosciences 50-day simple moving average is 2.19 while CLRB share price is 2.11, making it a Sell technically.
- CLRB stock price is 2.11 and Cellectar Biosciences 200-day simple moving average is 2.99, creating a Sell signal.
CLRB Technical Analysis vs Fundamental Analysis
Sell
44
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy or a Sell?
-
Cellectar Biosciences stock is rated a Sell
The current Cellectar Biosciences [CLRB] share price is $2.11. The Score for CLRB is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Cellectar Biosciences Stock Info
Market Cap:
75.64M
Price in USD:
2.11
Share Volume:
223.55K
Cellectar Biosciences 52-Week Range
52-Week High:
4.45
52-Week Low:
1.82
Sell
44
Cellectar Biosciences (CLRB)
is a Sell
Cellectar Biosciences Share Price Forecast
-
What is the Cellectar Biosciences stock price today?
The Cellectar Biosciences stock price is 2.11 USD today. -
Will CLRB stock go up or go down?
Cellectar Biosciences> share price is forecast to RISE/FALL based on technical indicators -
Is Cellectar Biosciences overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cellectar Biosciences is overvalued.
Is Cellectar Biosciences Stock a Buy?
- Cellectar Biosciences share price is 2.11 while CLRB 8-day exponential moving average is 2.11, which is a Buy signal.
- The stock price of CLRB is 2.11 while Cellectar Biosciences 20-day EMA is 2.12, which makes it a Sell.
- Cellectar Biosciences 50-day exponential moving average is 2.24 while CLRB share price is 2.11, making it a Sell technically.
- CLRB stock price is 2.11 and Cellectar Biosciences 200-day simple moving average is 2.67, creating a Sell signal.
Fundamental Analysis of Cellectar Biosciences
Is Cellectar Biosciences a good investment?
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.02 per share, an increase this year of $1.08 per share, and an increase next year of $1.21 per share.
Technical Analysis of Cellectar Biosciences
Should I short Cellectar Biosciences stock?
- CLRB Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting Cellectar Biosciences is a Sell
- Cellectar Biosciences Relative Strength Index (RSI) is 47.36, which suggest Cellectar Biosciences is oversold
- The Bollinger Bands (25) for Cellectar Biosciences is (2.07 - 2.17), which suggest Cellectar Biosciences is a Sell
- The Bollinger Bands (100) for Cellectar Biosciences is (2.1 - 3.08), which suggest Cellectar Biosciences is a Sell
* Cellectar Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.